Asher Bio (also known as Asher Biotherapeutics) is a biotechnology company developing cis-targeted immunotherapies for cancer and other diseases. It offers beneficial immunotherapies with precise selectivity, optimized efficacy, and minimized toxicity. The company aims to enable selective activation of specific immune cell types by precisely directing different immune mediators against a range of target immune cell types and creating immunotherapies in cancer, autoimmune and infectious diseases.